Human CD30/TNFRSF8 Protein (CD3-HM230)
$182.70 – $607.50
KACTUS Biosystems Human CD30/TNFRSF8 Protein (CD3-HM230) (catalog No. CD3-HM230) is expressed from HEK293 with hFc tag at the C-Terminus.It contains Phe19-Lys379.
- Details & Specifications
- References
- More Offers
| Catalog No. | CD3-HM230 |
|---|---|
| Product Name | Human CD30/TNFRSF8 Protein (CD3-HM230) |
| Supplier Name | KACTUS Biosystems |
| Brand Name | KACTUS Biosystems |
| Synonyms | CD30; CD30KI-1; CD30L receptor; TNFRSF8; D1S166EKi-1; CD30KI-1 |
| Species | Human |
| Source | HEK293 |
| Accession | P28908-1 |
| Product Tag | C-hFc |
| Biotinylated | no |
| Exact Sequence | Phe19-Lys379 |
| Molecular Weight | The protein has a predicted MW of 65.2 kDa. Due to glycosylation, the protein migrates to 80-115 kDa based on Tris-Bis PAGE result. |
| Form | Lyophilized |
| Formulation | Lyophilized from 0.22μm filtered solution in PBS (pH 7.4). Normally 8% trehalose is added as protectant before lyophilization. |
| Reconstitution | Centrifuge the tube before opening. Reconstituting to a concentration more than 100 μg/ml is recommended. Dissolve the lyophilized protein in distilled water. |
| Purity | > 95% as determined by Tris-Bis PAGE;> 95% as determined by HPLC |
| Endotoxin | Less than 1EU per μg by the LAL method. |
| Shipping | Shipped at ambient temperature. |
| Stability & Storage | '-20 to -80°C for 12 months as supplied from date of receipt.；-20 to -80°C for 3-6 months in unopened state after reconstitution.；2-8°C for 2-7 days after reconstitution.；Recommend to aliquot the protein into smaller quantities for optimal storage. Please minimize freeze-thaw cycles. |
| Note | Products will be shipped from the warehouse in Massachusetts. Promotion is running from time to time. Welcome to send a request for quote to message@sydlabs.com. |
| Order Offline | Syd Labs, Inc. 4 Avenue E, Hopkinton, MA 01748 USA. Phone: 1-617-401-8149 Fax: 1-617-606-5019 Email: message@sydlabs.com |
Description
CD3-HM230: Human CD30/TNFRSF8 Protein (CD3-HM230)
The transmembrane receptor CD30 (TNFRSF8) and its ligand CD30L (CD153, TNFSF8) are members of the tumor necrosis factor (TNF) superfamily and display restricted expression in subpopulations of activated T-and B-cells in nonpathologic conditions. CD30 expression is upregulated in various hematological malignancies, including Reed-Sternberg cells in Hodgkin’s disease (HD), anaplastic large cell lymphoma (ALCL) and subsets of Non-Hodgkin’s lymphomas (NHLs).
Please remember our product information: Human CD30/TNFRSF8 Protein (CD3-HM230) catalog number: CD3-HM230 KACTUS Biosystems
